Glioma-derived growth factor, GDGF, Osteosarcoma-derived Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858, PDGF-BB, PDGF B-chain, Platelet-derived growth factor beta polypeptide.
To reconstitute (dissolve) the lyophilized Platelet-derived Growth Factor-BB, it is recommended to use sterile 18 MΩ-cm H2O (high purity water) at a concentration of at least 100 µg/ml. This solution can be further diluted using other aqueous solutions if needed.
Glioma-derived growth factor, GDGF, Osteosarcoma-derived Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858, PDGF-BB, PDGF B-chain, Platelet-derived growth factor beta polypeptide.
Platelet-Derived Growth Factor BB (PDGF-BB) is a member of the PDGF family, which plays a crucial role in various biological processes, including development, cell proliferation, cell survival, and angiogenesis . PDGF-BB is a cystine-linked homodimer, meaning it consists of two identical subunits linked by disulfide bonds .
PDGF-BB has several key biological functions:
PDGF-BB exerts its effects by binding to PDGF receptors on the surface of target cells. This binding activates intracellular signaling pathways that lead to various cellular responses, including proliferation, migration, and survival . The primary receptors for PDGF-BB are PDGFR-α and PDGFR-β, which are tyrosine kinase receptors .
The activity of PDGF-BB is tightly regulated at multiple levels:
Recombinant human PDGF-BB (rhPDGF-BB) has been developed for therapeutic use, particularly in the field of regenerative medicine. It is used in combination with osteoconductive matrices, such as beta-tricalcium phosphate (β-TCP), to promote bone healing and tissue regeneration . Clinical trials have demonstrated that rhPDGF-BB is a safe and effective alternative to autografts for bone grafting procedures .